Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Conventional drugs

PreclinicalSmall molecule

UUniversity of Science and Technology, Yemen

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Functional Gastrointestinal DisordersRecruiting

Functional Gastrointestinal DisordersPreclinical

Recruiting

Timeline

Expected Milestones

Q3 2026

PreclinicalRecruiting

Functional Gastrointestinal Disorders

NCT05753774

Clinical

Trials by Indication[1]

Wisdom Tooth Removal1 trial

A Comparison of Recovery After Impacted Wisdom Tooth Removal

Completed·UUniversity of Science and Technology, Yemen·Phase 3·NCT07304882·24 enrolled

Functional Gastrointestinal Disorders1 trial

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Functional Gastrointestinal Disorders in Children

Recruiting·BBiao Zou·Preclinical·NCT05753774·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Conventional drugs. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Conventional drugs compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Conventional drugs. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Science and Technology, Yemen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Science and Technology, Yemen

Related News